-
India has been ranked among top 10 acquirers in the US market this year with 16 deals valued at $1.7 billion, says Baker & McKenzie.
-
Majority of the deals were in the pharma sector, with six transactions totalling $1.5 billion, as Indian companies seek to increase their scale in the US generics market.
-
India is witnessing more cross border M&A deals and beyond 2015, and the country could become a “sweetheart for US dealmakers”, as the Indian government continues to pursue reforms to open the economy to foreign investors, said the report.
Source: EconomicTimes